Company / Depreciation & Amortization
RECURSION PHARMACEUTICALS, INC. Depreciation & Amortization History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$83.7M
FY2025
5-year range
$3.9M / $83.7M
FY2021-FY2025
Trend
+129.4%
vs FY2024
Sector context
#24 of 163
Health Care
What the data says
RECURSION PHARMACEUTICALS, INC.'s depreciation & amortization of $84M is higher than 85% of companies in the Health Care sector (FY2025). Depreciation & Amortization has increased for 3 consecutive years, from $4M in FY2022 to $84M in FY2025.
Based on SEC 10-K filings.
$84M in FY2025 with a 5-year CAGR of +84.2%. Top quartile in the Health Care sector.
Increased from $24M to $84M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +176.9%
- 5-Year CAGR
- +84.2%
- 10-Year CAGR
- -
Sector benchmark
-61.9% below sector average
Key checks
Key Insights
- RECURSION PHARMACEUTICALS, INC.'s depreciation & amortization has grown for 3 consecutive years.
- 5-year CAGR of +84.2%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 129.4% year-over-year.
- Ranks #24 out of 163 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.80 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $83.7M | +129.4% |
| FY2024 | $36.5M | +49.6% |
| FY2023 | $24.4M | +518.9% |
| FY2022 | $3.9M | -53.1% |
| FY2021 | $8.4M | +113.2% |
| FY2020 | $3.9M | +58.4% |
| FY2019 | $2.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026